BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease
NCT07138560
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
22
Enrollment
OTHER
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
CREXONT ER
Sponsor
The Cleveland Clinic
Collaborators
[object Object]